Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISDIPLAM for Muscular dystrophy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where RISDIPLAM was used for Muscular dystrophy.

Most Reported Side Effects for RISDIPLAM

Side Effect Reports % Deaths Hosp.
No adverse event 324 9.0% 0 2
Diarrhoea 280 7.7% 1 37
Asthenia 209 5.8% 3 27
Pneumonia 182 5.0% 50 111
Death 165 4.6% 165 18
Pyrexia 152 4.2% 11 55
Fatigue 145 4.0% 0 15
Muscular weakness 125 3.5% 1 15
Vomiting 121 3.3% 4 48
Drug ineffective 115 3.2% 3 7
Headache 104 2.9% 0 11
Covid-19 103 2.9% 14 41
Rash 97 2.7% 4 12
Nausea 90 2.5% 1 25
Product dose omission issue 86 2.4% 1 16

Other Indications for RISDIPLAM

Spinal muscular atrophy (2,744) Product used for unknown indication (817) Muscle atrophy (38) Neuromyopathy (5)

Other Drugs Used for Muscular dystrophy

DEFLAZACORT (1,542) ETEPLIRSEN (100) CASIMERSEN (17) GOLODIRSEN (15) GIVINOSTAT (11) CELECOXIB (9) PREDNISONE (8) FENTANYL (7) PREGABALIN (7) METHOTREXATE (6)

Related Pages

RISDIPLAM Full Profile All Muscular dystrophy Drugs RISDIPLAM Demographics RISDIPLAM Timeline